These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 32941048

  • 1. Drug-Drug Binary Solids of Nitrofurantoin and Trimethoprim: Crystal Engineering and Pharmaceutical Properties.
    Maity DK, Paul RK, Desiraju GR.
    Mol Pharm; 2020 Dec 07; 17(12):4435-4442. PubMed ID: 32941048
    [Abstract] [Full Text] [Related]

  • 2. Development of antibacterial resistance: the Dutch experience.
    Beunders AJ.
    J Antimicrob Chemother; 1994 May 07; 33 Suppl A():17-22. PubMed ID: 7928833
    [Abstract] [Full Text] [Related]

  • 3. Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.
    Cherukuvada S, Babu NJ, Nangia A.
    J Pharm Sci; 2011 Aug 07; 100(8):3233-3244. PubMed ID: 21425165
    [Abstract] [Full Text] [Related]

  • 4. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug 07; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract] [Full Text] [Related]

  • 5. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P, Honderlick P.
    Pathol Biol (Paris); 2000 Jun 07; 48(5):470-1. PubMed ID: 10949843
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
    Anklesaria P, Paranjpe S, Gupta K, Acharya V, Paul T, Sheth UK.
    J Postgrad Med; 1976 Oct 07; 22(4):171-5. PubMed ID: 802242
    [No Abstract] [Full Text] [Related]

  • 7. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
    Rock W, Colodner R, Chazan B, Elias M, Raz R.
    Isr Med Assoc J; 2007 Nov 07; 9(11):803-5. PubMed ID: 18085038
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of the activity of trimethoprim-sulfamethopyrazine and nitrofurantoin in urinary infections of children].
    González E, Carranza C, Soto C, Romero P.
    Rev Chil Pediatr; 1985 Nov 07; 56(5):341-4. PubMed ID: 3915132
    [No Abstract] [Full Text] [Related]

  • 9. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
    Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ.
    Antimicrob Agents Chemother; 2000 Apr 07; 44(4):1089-92. PubMed ID: 10722520
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid.
    Keys TF.
    Mayo Clin Proc; 1977 Nov 07; 52(11):680-2. PubMed ID: 926843
    [Abstract] [Full Text] [Related]

  • 11. Trimethoprim-Based multicomponent solid Systems: Mechanochemical Screening, characterization and antibacterial activity assessment.
    Piccirillo G, Aroso R, Baptista JA, A E Castro R, da Silva GJ, Calvete MJF, Pereira MM, Canotilho J, Ermelinda S Eusébio M.
    Int J Pharm; 2024 Aug 15; 661():124416. PubMed ID: 38964490
    [Abstract] [Full Text] [Related]

  • 12. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG, Karlowsky JA, Schwartz B, Jensen SB, Hoban DJ.
    Chemotherapy; 1998 Aug 15; 44(6):391-6. PubMed ID: 9755298
    [Abstract] [Full Text] [Related]

  • 13. Nitrofurantoin: an effective and ignored antimicrobial.
    Arya SC, Agarwal N, Agarwal S.
    Int J Antimicrob Agents; 2006 Apr 15; 27(4):354-5. PubMed ID: 16531014
    [No Abstract] [Full Text] [Related]

  • 14. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
    Mulder M, Verbon A, Lous J, Goessens W, Stricker BH.
    Eur J Clin Microbiol Infect Dis; 2019 Dec 15; 38(12):2283-2290. PubMed ID: 31494829
    [Abstract] [Full Text] [Related]

  • 15. Nitrofurantoin-melamine monohydrate (cocrystal hydrate): Probing the role of H-bonding on the structure and properties using quantum chemical calculations and vibrational spectroscopy.
    Khan E, Shukla A, Jhariya AN, Tandon P, Vangala VR.
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Oct 05; 221():117170. PubMed ID: 31158769
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 17. Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?
    Wijma RA, Fransen F, Muller AE, Mouton JW.
    Drug Resist Updat; 2019 Mar 15; 43():1-9. PubMed ID: 30947111
    [Abstract] [Full Text] [Related]

  • 18. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH, Fukushima PI.
    Chemotherapy; 1979 Mar 15; 25(3):140-6. PubMed ID: 378572
    [Abstract] [Full Text] [Related]

  • 19. Increasing in vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug 15; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD, Freeman A, Foxman B.
    Clin Infect Dis; 2002 Apr 15; 34(8):1061-6. PubMed ID: 11914994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.